{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:33:46Z","timestamp":1793212426353,"version":"4.5.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,28]]},"DOI":"10.1093\/cid\/ciag303","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:32:01Z","timestamp":1777980721000},"page":"e913-e914","source":"Crossref","is-referenced-by-count":0,"title":["Atypical Hepatitis B Virus Serological Patterns After Switching to Long-Acting Cabotegravir\/Rilpivirine: Interpretation Within Current Definitions"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9253-3186","authenticated-orcid":false,"given":"Alberto","family":"Foncillas","sequence":"first","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-6686","authenticated-orcid":false,"given":"Juan","family":"Ambrosioni","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-5206","authenticated-orcid":false,"given":"Lorena","family":"de la Mora","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8365-141X","authenticated-orcid":false,"given":"Josep","family":"Mallolas","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0894-3711","authenticated-orcid":false,"given":"Ana","family":"Gonz\u00e1lez-Cord\u00f3n","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7798-6352","authenticated-orcid":false,"given":"Montserrat","family":"Laguno","sequence":"additional","affiliation":[{"name":"HIV Unit, Infectious Diseases Service, Hospital Cl\u00ednic Barcelona-Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026102813490711800_ciag303-B1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/cid\/ciag023","article-title":"Hepatitis B outcomes after switching to long-acting cabotegravir\/rilpivirine in people with HIV: reactivation, incident infection, and liver safety across diverse serological profiles","volume":"82","author":"Foncillas","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026102813490711800_ciag303-B2","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag305","article-title":"Anti-HBs seroconversion following withdrawal of anti-HBV-active agents: an underrecognized form of HBV reactivation?","author":"Adachi","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026102813490711800_ciag303-B3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"key":"2026102813490711800_ciag303-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcv.2017.08.008","article-title":"Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients","volume":"95","author":"Boyd","year":"2017","journal-title":"J Clin Virol"},{"key":"2026102813490711800_ciag303-B5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijid.2008.08.018","article-title":"Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa","volume":"13","author":"Firnhaber","year":"2009","journal-title":"Int J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag303\/68239407\/ciag303.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/4\/e913\/68239407\/ciag303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/4\/e913\/68239407\/ciag303.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:49:15Z","timestamp":1793209755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/4\/e913\/8671936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,7]]},"published-print":{"date-parts":[[2026,10,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag303","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,5,7]]}}}